MedPath

Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.

Phase 1
Conditions
Snoring
Sleep Apnea Syndromes
Registration Number
NCT00211627
Lead Sponsor
Miller, Chipp St. Kevin, M.D.
Brief Summary

Study to demonstrate the safety and effectiveness of a new oral enhanced airway device to treat simple snoring.

Detailed Description

The Keepasleep airway device is a novel and unique buccopharyngeal airway device to enhance breathing during sleep. This method has not been described in the medical literature and has been successful in limited testing. This clinical trial is to determine the safety and effectiveness of the KEEPASLEEP device utilizing 30 subjects with simple snoring. Each subject will serve as his/her own control. The device augments airflow into the posterior pharynx to minimize airway collapse,tissue vibration, and consequent snoring.The device passes through the retromaxillary space and requires that the subject be absent their wisdom teeth.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 18 yrs. of age or greater
  • generally good health
  • Intact dentition / ABSENT upper and lower wisdom teeth ( by extraction or lack of development )
  • Simple snoring( documented by observer) or mild sleep apnea RDI < 15 ( documented by polysomnogram)
  • Subject must have a concerned observer to assess of sleep and snoring behavior during trial period
Exclusion Criteria
  • Presence of Wisdom teeth (third molars)
  • active oral disease
  • acute illness
  • BMI (body mass index) > 30

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Reduction/Elimination of snoring behavior
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chipp St. Kevin Miller M.D.

🇺🇸

Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath